ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

ACCD Accolade Inc

3.48
0.065 (1.90%)
04 Jan 2025 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Accolade Inc NASDAQ:ACCD NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.065 1.90% 3.48 3.25 3.47 3.49 3.38 3.44 1,198,561 01:00:00

Accolade To Present at Morgan Stanley 22nd Annual Global Healthcare Conference

28/08/2024 1:00pm

GlobeNewswire Inc.


Accolade (NASDAQ:ACCD)
Historical Stock Chart


From Jul 2024 to Jan 2025

Click Here for more Accolade Charts.

Accolade, Inc. (NASDAQ: ACCD) today announced that it will be presenting at the Morgan Stanley 22nd Annual Global Healthcare Conference in New York on Thursday, September 5 at 9:15 am ET.

A webcast will be available at ir.accolade.com and a replay will be available for 90 days.

About Accolade, Inc.

Accolade (Nasdaq: ACCD) is a Personalized Healthcare company that provides millions of people and their families with exceptional healthcare experiences so they can live their healthiest lives. Accolade’s employer, health plan, and consumer solutions combine virtual primary care and mental health, expert medical opinion, and best-in-class care navigation. These offerings are built on a platform that is engineered to care through predictive engagement of population health needs, proactive care that improves outcomes and cost savings, and by addressing barriers to access and continuity of care. Accolade consistently receives consumer satisfaction ratings of over 90%. For more information, visit accolade.com. Follow us on LinkedIn, Twitter, Instagram and Facebook.

Investor Contact:

Todd Friedman, Investor Relations, IR@accolade.com

Source: Accolade

1 Year Accolade Chart

1 Year Accolade Chart

1 Month Accolade Chart

1 Month Accolade Chart

Your Recent History

Delayed Upgrade Clock